Tag: IgA nephropathy

Novartis to expand renal portfolio with Chinook Therapeutics acquisition

businessnewstoday- June 12, 2023

Novartis has announced its agreement to acquire Chinook Therapeutics, a clinical stage biopharmaceutical company based in Seattle, Washington in a deal worth up to around ... Read More

Chinook Therapeutics gets orphan drug status from EC for atrasentan in IgAN

pallavi123- December 15, 2021

Chinook Therapeutics, a US-based biopharma company, has secured orphan drug designation for atrasentan from the European Commission (EC) for the treatment of primary IgA nephropathy ... Read More

Calliditas initiates NEFIGARD trial to study Nefecon in Berger’s disease

pharmanewsdaily- November 14, 2018

Nefecon phase 3 trial : Calliditas Therapeutics has initiated a phase 3 clinical trial called NEFIGARD to evaluate its lead candidate Nefecon for the treatment ... Read More